Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77.6M
-
Number of holders
-
271
-
Total shares
-
72.1M
-
Shares change
-
-2.1M
-
Total reported value, excl. options
-
$4.14B
-
Value change
-
-$120M
-
Put/Call ratio
-
0.12
-
Number of buys
-
122
-
Number of sells
-
-116
-
Price
-
$57.41
Significant Holders of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) as of Q1 2023
272 filings reported holding IART - INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock as of Q1 2023.
INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) has 271 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72.1M shares
of 77.6M outstanding shares and own 92.88% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.03M shares), BlackRock Inc. (7.01M shares), MORGAN STANLEY (6.57M shares), Champlain Investment Partners, LLC (5.17M shares), WELLINGTON MANAGEMENT GROUP LLP (4.77M shares), Capital Research Global Investors (3.82M shares), ALLIANCEBERNSTEIN L.P. (2.93M shares), Clearbridge Investments, LLC (2.74M shares), COOKE & BIELER LP (2.66M shares), and STATE STREET CORP (2.17M shares).
This table shows the top 271 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.